Privia Health Group, Inc.

Privia Health Group, Inc. Q3 2025 Earnings Recap

PRVA Q3 2025 November 7, 2025

Get alerts when PRVA reports next quarter

Set up alerts — free

Privia Health reported robust third-quarter results, marked by significant growth in practice collections and adjusted EBITDA, leading to an upward revision of its 2025 financial guidance.

Earnings Per Share Miss
$0.05 vs $0.06 est.
-16.7% surprise
Revenue Beat
580419000 vs 516609300 est.
+12.4% surprise

Market Reaction

1-Day -2.29%
5-Day +1.0%
30-Day -0.79%

See PRVA alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Implemented provider growth of 13.1% year-over-year, reaching 5,250, driving practice collections up 27.1% to $940.4 million.
  • Adjusted EBITDA surged 61.6%, expanding the EBITDA margin to 30.5%, a 720 basis point improvement from the prior year.
  • Increased total attributed lives by nearly 13% year-over-year, with plans to further expand through the acquisition of an ACO business from Evolent Health, enhancing market presence and value-based services.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit PRVA on AllInvestView.

Get the Full Picture on PRVA

Track Privia Health Group, Inc. in your portfolio with real-time analytics, dividend tracking, and more.

View PRVA Analysis